Overcoming The Challenges Of Poorly Soluble Drugs
poorly soluble drugs, also known as poorly soluble compounds or poorly soluble active pharmaceutical ingredients (APIs), present a significant challenge in the pharmaceutical industry. These drugs have limited solubility in water and other physiological fluids, which can impact their bioavailability, efficacy, and ultimately, patient outcomes. In this article, we will explore the reasons behind the…